Esteban Masuda
Executive Vice President & Head of Research at Rigel Pharmaceuticals Inc @Rigel Pharmaceuticals Inc.
Signup · Get unlimited contacts
WORK HISTORY
Executive Vice President & Head of Research at Rigel Pharmaceuticals Inc @Rigel Pharmaceuticals Inc.
EDUCATION
Santa Ana College
Associate of Science - AS, Biological Sciences
University of California, Riverside
Bachelor of Science - BS, Biochemistry
Hiroshima University
Doctor of Philosophy - PhD, Biological Sciences
Osaka University of Foreign Studies
Certificate, Intensive Japanese Language
SKILLS
ABOUT ESTEBAN MASUDA
Esteban S. Masuda, Ph.D. is the Executive Vice President and Head of Research at Rigel Pharmaceuticals. He joined Rigel in 1998, and he has worked on and led numerous drug discovery projects in inflammatory and allergic diseases. He served as the project leader of the program that led to the discovery of Tavalisse™ (fostamatinib), a first in class SYK kinase inhibitor. His work has resulted in moving several product candidates into clinical development, establishing various corporate partnerships, producing over 50 publications, and issuing over 50 U.S. patents. Prior to joining Rigel, Dr. Masuda carried out his postdoctoral work on cytokine biology and gene regulation at DNAX Research Institute of Molecular and Cellular Biology (now part of Merck) in Palo Alto, CA.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.